Prevalence of anemia in inflammatory bowel diseases in European countries: A systematic review and individual patient data meta-analysis

Inflammatory Bowel Diseases

Volumn 20, Issue 5, 2014, Pages 936-945

  Filmann, Natalie ^a,b   Rey, Julia ^a   Schneeweiss, Sven ^b   Ardizzone, Sandro ^c   Bager, Palle ^d   Bergamaschi, Gaetano ^e   Koutroubakis, Ioannis ^f   Lindgren, Stefan ^g   De La Morena, Felipe ^h   Moum, Bjørn ⁱ   Vavricka, Stephan R ^j   Schröder, Oliver ^b   Herrmann, Eva ^a   Blumenstein, Irina ^b  

^a Institute of Biostatistics and Mathematical Modeling Faculty of Medicine   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY OF MILAN   (Italy)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^g LUND UNIVERSITY HOSPITAL   (Sweden)

^h HOSPITAL INFANTA CRISTINA   (Spain)

ⁱ OSLO UNIVERSITY HOSPITAL   (Norway)

^j TRIEMLI HOSPITAL   (Switzerland)

more..

Author keywords

Anemia; Crohn's disease; IBD; Meta analysis; Ulcerative colitis

Indexed keywords

FERRITIN; TRANSFERRIN;

ANEMIA; COLITIS; DISEASE ACTIVITY; EUROPE; HUMAN; INFLAMMATORY BOWEL DISEASE; META ANALYSIS; PATIENT CODING; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; REMISSION; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TERTIARY CARE CENTER; ULCERATIVE COLITIS; COMPLICATION; PROGNOSIS;

ANEMIA; EUROPE; HUMANS; INFLAMMATORY BOWEL DISEASES; PREVALENCE; PROGNOSIS;

EID: 84902193514     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.MIB.0000442728.74340.fd     Document Type: Review

References (31)

1. Pizzi LT, Weston CM, Goldfarb NI, et al. Impact of chronic conditions on quality of life in patients with inflammatory bowel disease. In flamm Bowel Dis. 2006;12:47-52.
2. Wells CW, Lewis S, Barton JR, et al. Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients. In flamm Bowel Dis. 2006;12:123-130.
3. Cucino C, Sonnenberg A. Cause of death in patients with inflammatory bowel disease. In flamm Bowel Dis. 2001;7:250-255.
4. Gasche C, Lomer MCE, Cavill I, et al. Iron, anaemia and inflammatory diseases. Gut. 2004;53:1190-1197.
5. Romberg-Camps MJL, Bol Y, Dagnelie PC, et al. Fatigue and health-related quality of life in inflammatory bowel disease: results from a population-based study in the Netherlands: the IBD-South Limburg Cohort. In flamm Bowel Dis. 2010;16:2137-2147.
6. Kulnigg S, Gasche C. Systematic review: managing anemia in Crohn's disease. Aliment Pharmacol Ther. 2006;24:1507-1523.
7. Gisbert JP, Gomollón F. Anemia and inflammatory bowel diseases. World J Gastroenterol. 2009;15:4659-4665.
8. Haapamäki J, Roine RP, Turunen U, et al. Increased risk for coronary heart disease, asthma, and connective tissue diseases in inflammatory bowel disease. J Crohns Colitis. 2011;5:41-47.
9. Blumenstein I, Bock H, Weber C, et al. Health care and cost of medication for inflammatory bowel disease in the Rhein-Main region, Germany: a multicenter, prospective, internet-based study. In flamm Bowel Dis. 2008;14:53-60.
10. Blumenstein I, Herrmann E, Filmann N, et al. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. J Crohns Colitis. 2011;5:203-210. doi:10.1016/j.crohns.2010.12.012.
11. World Health Organization. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A Guide for Programme Managers. Geneva, Switzerland: World Health Organization; 2001. (WHO/NHD/01.3).
12. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
13. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607-611.
14. Miller JJ. The inverse of the Freeman-Tukey double arcsine transformation. Am Stat. 1978;32:138.
15. Pinheiro JC, Bates DM. Mixed-effects Models in S and S-Plus. New York, NY: Statistics and Computing Series, Springer; 2009.
16. Bager P, Befrits R, Wikman O, et al. The prevalence of anemia and iron deficiency in IBD outpatients in Scandinavia. Scand J Gastroenterol. 2011;46:304-309.
17. Oustamanolakis P, Koutroubakis IE, Messaritakis I, et al. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease. J Crohns Colitis. 2011;5:295-300.
18. Bergamaschi G, Di Sabatino A, Albertini R, et al. Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of antitumor necrosis factor-alpha treatment. Haematologica. 2010;95:199-205.
19. De la Morena LP, Gisbert JP. Prevalence and characteristics of anemia in inflammatory bowel diseases. Gastroenterol Hepatol. 2009;32:391-399.
20. Voegtlin M, Vavricka SR, Schoepfer AM, et al. Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from practices and university hospitals. J Crohns Colitis. 2010; 4:642-648.
21. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Bull World Health Organ. 2007; 85:867-872.
22. Liberati A, Altman DG, Tetzlaff J, et al The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
23. Rejler M, Tholstrup J, Andersson-Gäre B, et al. Low prevalence of anemia in inflammatory bowel disease: a population-based study in Sweden. Scand J Gastroenterol. 2012;47:937-942.
24. Goodhand JR, Kamperidis N, Rao A, et al. Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease. In flamm Bowel Dis. 2012;18:513-519.
25. Vijverman A, Piront P, Belaiche J, et al. Evolution of the prevalence and characteristics of anemia in inflammatory bowel diseases between 1993 and 2003. Acta Gastroenterol Belg. 2006;69:1-4.
26. Ebinger M, Leidl R, Thomas S, et al. Cost of outpatients with inflammatory bowel disease in a German University Hospital. J Gastroenterol Hepatol. 2004;19:192-199.
27. Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: result of a 25-year follow-up-study. World J Gastroenterol. 2003;9:2300-2307.
28. Gasche C, Berstad A, Befrits R, et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. In flamm Bowel Dis. 2007;13:1545-1553.
29. Gisbert JP, Gomollón F. Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease. Am J Gastroentrol. 2008;103:1299-1307.
30. Wilson A, Reyes E, Ofman J. Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med. 2004;116(suppl 7A):44S-49S.
31. Van Assche G, Dignass A, Bokemeyer B, et al. European Crohn's and Colitis Organisation. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis. 2013;7:1-33.